Cargando…

Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy

Radiotherapy is crucial and substantially contributes to multimodal cancer treatment. The combination of conventional fractionation radiotherapy (CFRT) and systemic therapy has been established as the standard treatment for many cancer types. With advances in linear accelerators and image-guided tec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ying-Chieh, Chiang, Chi-Shiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927577/ https://www.ncbi.nlm.nih.gov/pubmed/27446811 http://dx.doi.org/10.3389/fonc.2016.00165

Ejemplares similares

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
por: Hellevik, Turid, et al.
Publicado: (2014)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
por: Børresen, Betina, et al.
Publicado: (2023)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
por: Herskind, Carsten, et al.
Publicado: (2017)

Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?
por: Yuce Sari, Sezin, et al.
Publicado: (2021)

Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
por: Lee, Yu-Hung, et al.
Publicado: (2021)

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
por: Joseph, Nuradh, et al.
Publicado: (2022)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy
por: Elbanna, May, et al.
Publicado: (2021)

Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery
por: Lagerwaard, Frank, et al.
Publicado: (2018)

Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects
por: Bresolin, Andrea, et al.
Publicado: (2020)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis
por: Tang, Xiaofang, et al.
Publicado: (2020)

Low-Dose Radiotherapy Versus Moderate-Dose Radiotherapy for the Treatment of Indolent Orbital Adnexal Lymphomas
por: Baron, Jonathan, et al.
Publicado: (2021)

Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
por: Chi, Mau-Shin, et al.
Publicado: (2020)

Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy
por: Chiang, Chi-Leung, et al.
Publicado: (2019)

High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up
por: Ishiyama, Hiromichi, et al.
Publicado: (2014)

Impact of Inter-fractional Anatomical Changes on Dose Distributions in Passive Carbon-Ion Radiotherapy for Prostate Cancer: Comparison of Vertical and Horizontal Fields
por: Yokoyama, Ayaka, et al.
Publicado: (2020)

Adjuvant single-fraction radiotherapy is safe and effective for intractable keloids
por: Song, Changhoon, et al.
Publicado: (2014)

Combining distance and anatomical information for deep-learning based dose distribution predictions for nasopharyngeal cancer radiotherapy planning
por: Chen, Xinyuan, et al.
Publicado: (2023)

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
por: Takeda, Atsuya, et al.
Publicado: (2014)

Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
por: Wilson, Joseph D., et al.
Publicado: (2020)

Key changes in the future clinical application of ultra-high dose rate radiotherapy
por: Lin, Binwei, et al.
Publicado: (2023)

Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Chiang, Chi-Leung, et al.
Publicado: (2021)

Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
por: Yuan, Meng, et al.
Publicado: (2022)

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012)

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
por: Wilson, Joseph D., et al.
Publicado: (2020)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma
por: Amidon, Ryan F., et al.
Publicado: (2022)

Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022)

Radiotherapy in Combination With Cytokine Treatment
por: Palata, Ondrej, et al.
Publicado: (2019)

Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”
por: Chow, Ronald, et al.
Publicado: (2021)

Potential Applications of Image-Guided Radiotherapy for Radiation Dose Escalation in Patients with Early Stage High-Risk Prostate Cancer
por: Nguyen, Nam P., et al.
Publicado: (2015)

Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy
por: Sun, Tao, et al.
Publicado: (2020)

Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients
por: Chen, Tian, et al.
Publicado: (2023)

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
por: Yu, Siting, et al.
Publicado: (2022)

Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution
por: Sitathanee, Chomporn, et al.
Publicado: (2021)

Resection Followed by Involved-Field Fractionated Radiotherapy in the Management of Single Brain Metastasis
por: Shin, Samuel M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dgf0k18cc2dvuhulnuo4qk8prn